Quotient Clinical

Sector Healthcare
Location London
Date acquired 2013
Transaction size Not disclosed

A provider of outsourced, early-stage drug development services to the global pharmaceutical and biotechnology industries


It was sold to GHO Capital in 2015.

This investment was made by Bridgepoint Development Capital.

To learn more about the company, click here.

Headquartered in Nottingham in the UK, Quotient has developed a platform which offers an integrated approach to formulation development, ‘real-time’ drug product manufacturing and clinical testing. Using this platform has been proven to significantly reduce the time and cost of the early-stage drug development process.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.